-+ 0.00%
-+ 0.00%
-+ 0.00%

GENERATE BIOMEDICINES - GB-5267 TARGETS MUC16 BIOMARKER IN OVER 80% OF OVARIAN TUMORS

Reuters·10/01/2026 11:06:18